A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma
Abstract Background Nasopharyngeal carcinoma (NPC) is a malignant tumor prevalent in Southern China, strongly associated with Epstein-Barr virus (EBV) infection. Accurate diagnosis is critical in determining treatment strategies for NPC. In clinical practice, imaging techniques are the most predomin...
Saved in:
| Main Authors: | Yi-Xi Pan, Qi Huang, Shan Xing, Qian-Ying Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-13958-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma
by: Yaoshu Teng, et al.
Published: (2020-01-01) -
Pre-treatment serum apolipoprotein E: a promising prognostic indicator for nasopharyngeal carcinoma
by: Xian-Ming He, et al.
Published: (2025-06-01) -
Molecular diagnosis of nasopharyngeal carcinoma: Past and future
by: Cheng-Lung Hsu, et al.
Published: (2025-02-01) -
CACA guidelines for holistic integrative management of adolescent and childhood nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2025-07-01) -
Use of camrelizumab in treatment of nasopharyngeal carcinoma
by: Yu. V. Alymov, et al.
Published: (2024-12-01)